logo
Quick Facts
  

JD.com Appoints Lei Xu As President

By RTTNews Staff Writer   ✉   | Published:

JD.com Inc. (JD) announced the appointment of Lei Xu as President of JD.com, Lijun Xin as CEO of JD Retail and Enlin Jin as CEO of JD Health International Inc., effective immediately.

The company noted that Richard Qiangdong Liu, Chairman and CEO of JD.com, will devote more time to formulating the Company's long-term strategies, mentoring younger management, and contributing to the revitalization of rural areas.

Xu has been with the company since 2009 and was previously CEO of JD Retail, responsible for the development, operation and strategy of JD.com's retail business.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Elon Musk's Neuralink Gets FDA Approval For Human Trials
Elon Musk's brain implant firm Neuralink said it has received approval from the U.S. Food and Drug Administration to conduct first-in-human clinical trials. In a tweet, Neuralink said, "We are excited to share that we have received the FDA's approval to launch our first-in-human clinical study!
T.W. Garner Food Recalls Texas Pete Buffalo Wing Sauce
T.W. Garner Food Co. is recalling 50,688 bottles of 12 oz. Texas Pete Buffalo Wing Sauce citing undeclared soy, the U.S. Food and Drug Administration said. The agency noted that some of the bottles may contain Texas Pete Extra Mild Wing Sauce which contains soy. The recall involves Texas Pete Buffalo Wing Sauce with best used by 120623T 065239 UPC 0 75500 10011 6.
FDA Approves Pfizer's COVID-19 Pill Paxlovid
The U.S. Food and Drug Administration approved Pfizer Inc's COVID-19 oral antiviral pill Paxlovid for the treatment of mild-to-moderate COVID-19 in adults. Paxlovid is the first oral treatment, and the fourth drug, approved by the agency to treat COVID-19 in adults. Paxlovid (nirmatrelvir tablets and ritonavir tablets, co-packaged for oral use) has been approved to treat adults who are at high...
Latest Updates on COVID-19
Read More
COVID-19: Drugs in Development
Follow RTT
Copyright © 2023 RTTNews. All rights reserved. By using this site, you agree to the Terms of Service. About Us   |   Contact Us   |   Privacy   |   Sitemap